Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Heritability and genetic variance of dementia with Lewy bodies.

Journal article

Guerreiro R. et al, (2019), Neurobiol Dis, 127, 492 - 501

A comprehensive screening of copy number variability in dementia with Lewy bodies

Journal article

Kun-Rodrigues C. et al, (2019), Neurobiology of Aging, 75, 223.e1 - 223.e10

Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease

Journal article

Ruffmann C. et al, (2018), Neuropathology and Applied Neurobiology, 44, 722 - 736

LRP10 in α-synucleinopathies

Journal article

Guerreiro R. et al, (2018), The Lancet Neurology, 17, 1032 - 1033

Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study

Journal article

Guerreiro R. et al, (2018), The Lancet Neurology, 17, 64 - 74

DNAJC12 and dopa-responsive nonprogressive parkinsonism

Journal article

Straniero L. et al, (2017), Annals of Neurology, 82, 640 - 646

Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies

Journal article

Kun-Rodrigues C. et al, (2017), Neurobiology of Aging, 49, 214.e13 - 214.e15

DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study

Journal article

Trinh J. et al, (2016), The Lancet Neurology, 15, 1248 - 1256

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies

Journal article

Fairfoul G. et al, (2016), Annals of Clinical and Translational Neurology, 3, 812 - 818

α-synuclein genetic variability: A biomarker for dementia in Parkinson disease

Journal article

Guella I. et al, (2016), Annals of Neurology, 79, 991 - 999

Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases

Journal article

Guerreiro R. et al, (2016), Neurobiology of Aging, 38, 214.e7 - 214.e10

Gut Feelings About α-Synuclein in Gastrointestinal Biopsies: Biomarker in the Making?

Journal article

Ruffmann C. and Parkkinen L., (2016), Movement Disorders, 31, 193 - 202

Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson diseaseAuthor Response

Journal article

Ruffmann C. et al, (2015), Neurology, 85, 834 - 835

Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology

Journal article

Vaikath NN. et al, (2015), Neurobiology of Disease, 79, 81 - 99

NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases

Journal article

Nalls MA. et al, (2015), Neurobiology of Aging, 36, 1605.e7 - 1605.e12

Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies

Journal article

Bras J. et al, (2014), Human Molecular Genetics, 23, 6139 - 6146

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

Journal article

Nalls MA. et al, (2014), Nature Genetics, 46, 989 - 993

Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse

Journal article

Taylor TN. et al, (2014), Neurobiology of Disease, 62, 193 - 207

The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related Dementia

Journal article

Compta Y. et al, (2014), Neurodegenerative Diseases, 13, 154 - 156

Load More